JP2020516264A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516264A5 JP2020516264A5 JP2019555196A JP2019555196A JP2020516264A5 JP 2020516264 A5 JP2020516264 A5 JP 2020516264A5 JP 2019555196 A JP2019555196 A JP 2019555196A JP 2019555196 A JP2019555196 A JP 2019555196A JP 2020516264 A5 JP2020516264 A5 JP 2020516264A5
- Authority
- JP
- Japan
- Prior art keywords
- hbv
- immunogen
- viral vector
- expression cassette
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1705765.4A GB201705765D0 (en) | 2017-04-10 | 2017-04-10 | HBV vaccine |
| GB1705765.4 | 2017-04-10 | ||
| PCT/GB2018/050948 WO2018189522A1 (en) | 2017-04-10 | 2018-04-10 | Hbv vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516264A JP2020516264A (ja) | 2020-06-11 |
| JP2020516264A5 true JP2020516264A5 (enExample) | 2021-05-20 |
| JP7326157B2 JP7326157B2 (ja) | 2023-08-15 |
Family
ID=58744773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019555196A Active JP7326157B2 (ja) | 2017-04-10 | 2018-04-10 | Ｈｂｖワクチン |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20200113998A1 (enExample) |
| EP (1) | EP3609535B1 (enExample) |
| JP (1) | JP7326157B2 (enExample) |
| KR (1) | KR102700586B1 (enExample) |
| CN (2) | CN118576699A (enExample) |
| AU (1) | AU2018251241B2 (enExample) |
| CA (1) | CA3059290A1 (enExample) |
| DK (1) | DK3609535T3 (enExample) |
| ES (1) | ES3036962T3 (enExample) |
| GB (1) | GB201705765D0 (enExample) |
| MX (1) | MX2019012101A (enExample) |
| MY (1) | MY202396A (enExample) |
| PH (1) | PH12019502310A1 (enExample) |
| SG (1) | SG11201909353VA (enExample) |
| WO (1) | WO2018189522A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA202091513A1 (ru) | 2017-12-19 | 2020-09-09 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Вакцины против вируса гепатита b (hbv) и их применение |
| EA202091516A1 (ru) | 2017-12-19 | 2020-11-03 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv) |
| EA202091517A1 (ru) | 2017-12-19 | 2020-11-03 | Янссен Сайенсиз Айрлэнд Анлимитед Компани | Способы и устройство для доставки вакцин против вируса гепатита b (hbv) |
| BR112021017584A2 (pt) * | 2019-03-05 | 2021-11-09 | Glaxosmithkline Biologicals Sa | Regime e composições de imunização contra hepatite b |
| WO2020255008A1 (en) * | 2019-06-18 | 2020-12-24 | Janssen Sciences Ireland Unlimited Company | COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND HBV-TARGETING RNAi |
| EP3986458A1 (en) * | 2019-06-20 | 2022-04-27 | Janssen Sciences Ireland Unlimited Company | Self-replicating rna molecules for hepatitis b virus (hbv) vaccines and uses thereof |
| BR112022003474A2 (pt) | 2019-08-29 | 2022-05-24 | Triad Nat Security Llc | Vacinas do vírus da hepatite b |
| HRP20241379T1 (hr) | 2019-09-30 | 2024-12-20 | Gilead Sciences, Inc. | Cjepiva za hbv i postupci za liječenje hbv |
| WO2021243149A2 (en) * | 2020-05-28 | 2021-12-02 | President And Fellows Of Harvard College | Protein covariance networks reveal interactions important to the emergence of sars coronaviruses as human pathogens |
| IL299571A (en) * | 2020-07-08 | 2023-02-01 | Janssen Sciences Ireland Unlimited Co | Rna replicon vaccines against hbv |
| WO2022071513A1 (ja) | 2020-10-02 | 2022-04-07 | 国立大学法人大阪大学 | ＳＡＲＳ－ＣｏＶ－２に対する改良型ＤＮＡワクチン |
| TW202245809A (zh) * | 2020-12-18 | 2022-12-01 | 美商詹森藥物公司 | 用於治療b型肝炎病毒感染之組合療法 |
| CN115595312A (zh) * | 2021-06-28 | 2023-01-13 | 中国农业大学（Cn） | 一种重组腺病毒及其应用 |
| US20250000968A1 (en) * | 2021-11-12 | 2025-01-02 | The United States of America, as represented by the Secretary,Department of Health and Human Service | Sars-cov-2 spike fused to a hepatitis b surface antigen |
| EP4444347A1 (en) | 2021-12-07 | 2024-10-16 | Barinthus Biotherapeutics (UK) Limited | Vaccine boost methods and compositions |
| CN121443308A (zh) * | 2023-03-17 | 2026-01-30 | 亥姆霍兹慕尼黑中心-德国健康与环境研究中心(有限公司) | 用于治疗乙型肝炎的hbv抗原制剂 |
| GB202317925D0 (en) | 2023-11-23 | 2024-01-10 | Spybiotech Ltd | Vaccines |
| CN118593695B (zh) * | 2024-08-07 | 2024-10-22 | 山东兴瑞生物科技有限公司 | 一种用于治疗HBV感染的siRNA和mRNA联合疫苗 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994012617A1 (en) | 1992-11-25 | 1994-06-09 | International Biotechnology Laboratories, Inc. | Hepatitis b virus vaccines |
| WO2005017149A1 (en) * | 2003-06-03 | 2005-02-24 | Cell Genesys, Inc. | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| WO2008020656A1 (en) * | 2006-08-14 | 2008-02-21 | Postech Foundation | A dna vaccine for curing chronic hepatitis b and a method of preparing same |
| US10076570B2 (en) | 2009-08-07 | 2018-09-18 | Transgene S.A. | Composition for treating HBV infection |
| CA2770075C (en) * | 2009-08-07 | 2021-08-24 | Perrine Martin | Composition for treating hbv infection |
| PE20140844A1 (es) * | 2011-02-12 | 2014-07-14 | Globeimmune Inc | Terapeuticos a base de levadura para infeccion de la hepatitis b cronica |
| TWI575070B (zh) * | 2011-07-12 | 2017-03-21 | 傳斯堅公司 | Ｈｂｖ聚合酶突變體 |
| CN103173492B (zh) * | 2013-03-12 | 2014-08-13 | 中国人民解放军白求恩国际和平医院 | 携带外源基因的复制型hbv载体、其转染后产生的重组hbv，和相应的制备方法与应用 |
| GB201321384D0 (en) * | 2013-12-04 | 2014-01-15 | Isis Innovation | Molecular adjuvant |
-
2017
- 2017-04-10 GB GBGB1705765.4A patent/GB201705765D0/en not_active Ceased
-
2018
- 2018-04-10 CN CN202410387306.0A patent/CN118576699A/zh active Pending
- 2018-04-10 DK DK18719248.9T patent/DK3609535T3/da active
- 2018-04-10 AU AU2018251241A patent/AU2018251241B2/en active Active
- 2018-04-10 CA CA3059290A patent/CA3059290A1/en active Pending
- 2018-04-10 KR KR1020197031896A patent/KR102700586B1/ko active Active
- 2018-04-10 EP EP18719248.9A patent/EP3609535B1/en active Active
- 2018-04-10 JP JP2019555196A patent/JP7326157B2/ja active Active
- 2018-04-10 ES ES18719248T patent/ES3036962T3/es active Active
- 2018-04-10 CN CN201880028408.6A patent/CN110913899B/zh active Active
- 2018-04-10 WO PCT/GB2018/050948 patent/WO2018189522A1/en not_active Ceased
- 2018-04-10 SG SG11201909353V patent/SG11201909353VA/en unknown
- 2018-04-10 MY MYPI2019005911A patent/MY202396A/en unknown
- 2018-04-10 US US16/604,221 patent/US20200113998A1/en not_active Abandoned
- 2018-04-10 MX MX2019012101A patent/MX2019012101A/es unknown
-
2019
- 2019-10-08 PH PH12019502310A patent/PH12019502310A1/en unknown
-
2023
- 2023-06-06 US US18/206,249 patent/US12521431B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7326157B2 (ja) | Ｈｂｖワクチン | |
| CN1180843C (zh) | 多表位疫苗 | |
| JP6702725B2 (ja) | 改良されたポックスウイルスワクチン | |
| EP2408473B1 (en) | Vaccination methods | |
| JP2020536489A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| KR20180100228A (ko) | Hbv를 치료하기 위한 수단 및 방법 | |
| JP2017522907A5 (enExample) | ||
| JP2003511010A (ja) | ヒト細胞中での発現用に最適化された合成ヒトパピローマウイルス遺伝子 | |
| CA2683679A1 (en) | Adenoviral vector encoding malaria antigen | |
| JP2016510989A5 (enExample) | ||
| EP2391383B1 (en) | Codon-optimized hepatitis b virus core antigen (hbcag) | |
| JP2022513326A5 (enExample) | ||
| RU2018122755A (ru) | Слитые белки fmdv-e2 и их применение | |
| WO2007119279A1 (ja) | コイヘルペスウイルス（ｋｈｖ）病用ｄｎａワクチン | |
| CN111741766A (zh) | 用于诱导针对乙型肝炎病毒(hbv)的免疫应答的方法和组合物 | |
| JP2023528984A (ja) | コロナウイルス病に対する組換え修飾ワクシニアウイルスアンカラ（ｍｖａ）ワクチン | |
| US20160324954A1 (en) | Immunogenic compositions for inhibiting hepatitis d virus | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| KR101863335B1 (ko) | 어류 바이러스성 출혈성 패혈증에 대한 예방 또는 치료용 dna 백신 | |
| CN102000330B (zh) | 一种核酸疫苗佐剂及其构建方法 | |
| JP2013512256A5 (enExample) | ||
| Basirnejad et al. | Development of HCV therapeutic vaccines using Hp91 peptide and small heat shock protein 20 as an adjuvant | |
| CN1059927C (zh) | 羧端带有前表面抗原1抗原决定簇的乙肝表面抗原融合基因及其编码蛋白 | |
| TH1901006450A (th) | วัคซีน hbv |